speb/financial-data huggingface dataset:
CRNT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 23867000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 690000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Other Payable: 23167000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Other Properties: 57567000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Other Receivables: 23804000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Payables: 88743000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 88743000.00
CRNT income_statement (quarterly, 2026-03-31) — Pretax Income: -771000.00
CRNT cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 9000.00
CRNT cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
CRNT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2275000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Receivables: 118225000.00
CRNT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 54927000.00
CRNT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3434000.00
CRNT cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1900000.00
CRNT income_statement (quarterly, 2026-03-31) — Research And Development: 7941000.00
CRNT income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 540000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -254558000.00
CRNT income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 13990000.00
CRNT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 19510000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Share Issued: 94358478.00
CRNT income_statement (quarterly, 2026-03-31) — Special Income Charges: -540000.00
CRNT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 892000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 171496000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 136622000.00
CRNT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -216000.00
CRNT income_statement (quarterly, 2026-03-31) — Tax Provision: 572000.00
CRNT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CRNT balance_sheet (quarterly, 2026-03-31) — Total Assets: 307354000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 171496000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Total Debt: 33567000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 171496000.00
CRNT income_statement (quarterly, 2026-03-31) — Total Expenses: 82378000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 135858000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 93509000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 23348000.00
CRNT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 2085000.00
CRNT income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 2856000.00
CRNT income_statement (quarterly, 2026-03-31) — Total Unusual Items: -540000.00
CRNT income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -540000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 8248000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 3481523.00
CRNT balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 20091000.00
CRNT balance_sheet (quarterly, 2026-03-31) — Working Capital: 101335000.00
CRNX balance_sheet (annual, 2021-12-31) — Accrued Interest Receivable: 499000.00
CRNX income_statement (annual, 2021-12-31) — Basic Average Shares: 38436000.00
CRNX income_statement (annual, 2021-12-31) — Basic EPS: -2.80
CRNX cash_flow (annual, 2021-12-31) — Change In Account Payable: 6293000.00
CRNX cash_flow (annual, 2021-12-31) — Change In Payable: 6293000.00
CRNX cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: 6293000.00
CRNX cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
CRNX income_statement (annual, 2021-12-31) — Diluted Average Shares: 38436000.00
CRNX income_statement (annual, 2021-12-31) — Diluted EPS: -2.80
CRNX balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 553000.00
CRNX balance_sheet (annual, 2021-12-31) — Financial Assets: 68000.00
CRNX balance_sheet (annual, 2021-12-31) — Investments And Advances: 1010000.00
CRNX balance_sheet (annual, 2021-12-31) — Investmentsin Subsidiariesat Cost: 1010000.00
CRNX balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 1010000.00
CRNX balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 939000.00
CRNX balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 2000.00
CRNX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 8984000.00
CRNX cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
CRNX balance_sheet (annual, 2021-12-31) — Restricted Common Stock: 2000.00
CRNX balance_sheet (annual, 2021-12-31) — Taxes Receivable: 977000.00
CRNX income_statement (annual, 2022-12-31) — +Operating Expense: 172619000.00
CRNX income_statement (annual, 2022-12-31) — +Total Revenue: 4737000.00
CRNX balance_sheet (annual, 2022-12-31) — Accounts Payable: 6883000.00
CRNX balance_sheet (annual, 2022-12-31) — Accrued Interest Receivable: 1353000.00
CRNX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -4084000.00
CRNX cash_flow (annual, 2022-12-31) — Amortization Of Securities: 34000.00
CRNX income_statement (annual, 2022-12-31) — Basic Average Shares: 51982000.00
CRNX income_statement (annual, 2022-12-31) — Basic EPS: -3.15
CRNX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 201195000.00
CRNX cash_flow (annual, 2022-12-31) — Capital Expenditure: -1656000.00
CRNX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3075000.00
CRNX balance_sheet (annual, 2022-12-31) — Capital Stock: 759432000.00
CRNX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 32672000.00
CRNX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 334425000.00
CRNX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 121963000.00
CRNX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -173980000.00
CRNX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -115205000.00
CRNX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -938000.00
CRNX cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 8341000.00
CRNX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 215000.00
CRNX cash_flow (annual, 2022-12-31) — Change In Receivables: 10994000.00
CRNX cash_flow (annual, 2022-12-31) — Change In Working Capital: 18612000.00
CRNX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 10994000.00
CRNX cash_flow (annual, 2022-12-31) — Changes In Cash: -167222000.00
CRNX balance_sheet (annual, 2022-12-31) — Common Stock: 759432000.00
CRNX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 316328000.00
CRNX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 117242000.00
CRNX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 8468000.00
CRNX balance_sheet (annual, 2022-12-31) — Current Assets: 345184000.00
CRNX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1051000.00
CRNX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1051000.00
CRNX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 2240000.00
CRNX balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 2240000.00
CRNX balance_sheet (annual, 2022-12-31) — Current Liabilities: 27723000.00
CRNX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 983000.00
CRNX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 983000.00
CRNX income_statement (annual, 2022-12-31) — Diluted Average Shares: 51982000.00
CRNX income_statement (annual, 2022-12-31) — Diluted EPS: -3.15
CRNX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -163918000.00
CRNX balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 135000.00
CRNX income_statement (annual, 2022-12-31) — EBIT: -167882000.00
CRNX income_statement (annual, 2022-12-31) — EBITDA: -166899000.00
CRNX income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -1010000.00
CRNX cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 1010000.00
CRNX cash_flow (annual, 2022-12-31) — End Cash Position: 33973000.00
CRNX balance_sheet (annual, 2022-12-31) — Financial Assets: 668000.00
CRNX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 121963000.00
CRNX cash_flow (annual, 2022-12-31) — Free Cash Flow: -116861000.00
CRNX cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -600000.00
CRNX cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
CRNX income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 600000.00
CRNX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -3931000.00
CRNX income_statement (annual, 2022-12-31) — General And Administrative Expense: 42394000.00
CRNX balance_sheet (annual, 2022-12-31) — Gross PPE: 9070000.00
CRNX income_statement (annual, 2022-12-31) — Interest Income: 4317000.00
CRNX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 4317000.00
CRNX balance_sheet (annual, 2022-12-31) — Invested Capital: 316328000.00
CRNX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -173980000.00
CRNX balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
CRNX balance_sheet (annual, 2022-12-31) — Investmentsin Subsidiariesat Cost: 0.00
CRNX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 117242000.00
CRNX balance_sheet (annual, 2022-12-31) — Leases: 3516000.00
CRNX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2024000.00
CRNX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2024000.00
CRNX balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 0.00
CRNX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 900000.00
CRNX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 117242000.00
CRNX income_statement (annual, 2022-12-31) — Net Income: -163918000.00
CRNX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -163918000.00
CRNX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -163918000.00
CRNX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -163918000.00
CRNX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -163918000.00
CRNX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -163918000.00
CRNX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -163918000.00
CRNX income_statement (annual, 2022-12-31) — Net Interest Income: 4317000.00
CRNX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -172324000.00
CRNX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 4317000.00
CRNX balance_sheet (annual, 2022-12-31) — Net PPE: 4986000.00
CRNX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1656000.00
CRNX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 316328000.00
CRNX balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 6101000.00
CRNX balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 6101000.00
CRNX income_statement (annual, 2022-12-31) — Normalized EBITDA: -167499000.00
CRNX income_statement (annual, 2022-12-31) — Normalized Income: -164518000.00
CRNX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -115205000.00
CRNX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 410000.00
CRNX income_statement (annual, 2022-12-31) — Operating Income: -167882000.00
CRNX income_statement (annual, 2022-12-31) — Operating Revenue: 4737000.00
CRNX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 53877000.00
CRNX balance_sheet (annual, 2022-12-31) — Other Current Assets: 1930000.00
CRNX balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1051000.00
CRNX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -3931000.00
CRNX income_statement (annual, 2022-12-31) — Other Gand A: 42394000.00
CRNX income_statement (annual, 2022-12-31) — Other Income Expense: -353000.00
CRNX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 406000.00
CRNX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1338000.00
CRNX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 57000.00
CRNX balance_sheet (annual, 2022-12-31) — Other Properties: 4654000.00
CRNX balance_sheet (annual, 2022-12-31) — Other Receivables: 605000.00
CRNX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 301753000.00
CRNX balance_sheet (annual, 2022-12-31) — Payables: 6883000.00
CRNX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 15351000.00
CRNX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 9081000.00
CRNX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CRNX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 5799000.00
CRNX income_statement (annual, 2022-12-31) — Pretax Income: -163918000.00
CRNX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 4721000.00
CRNX balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRNX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -329817000.00
CRNX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1656000.00
CRNX balance_sheet (annual, 2022-12-31) — Receivables: 3030000.00
CRNX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 983000.00
CRNX income_statement (annual, 2022-12-31) — Research And Development: 130225000.00
CRNX balance_sheet (annual, 2022-12-31) — Retained Earnings: -439173000.00
CRNX cash_flow (annual, 2022-12-31) — Sale Of Investment: 157493000.00
CRNX income_statement (annual, 2022-12-31) — Selling General And Administration: 42394000.00
CRNX balance_sheet (annual, 2022-12-31) — Share Issued: 53877000.00
CRNX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 28268000.00
CRNX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 316328000.00
CRNX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 316328000.00
CRNX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CRNX balance_sheet (annual, 2022-12-31) — Taxes Receivable: 937000.00
CRNX balance_sheet (annual, 2022-12-31) — Total Assets: 352176000.00
CRNX balance_sheet (annual, 2022-12-31) — Total Capitalization: 316328000.00
CRNX balance_sheet (annual, 2022-12-31) — Total Debt: 3075000.00
CRNX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 316328000.00
CRNX income_statement (annual, 2022-12-31) — Total Expenses: 172619000.00
CRNX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 35848000.00
CRNX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6992000.00
CRNX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 8125000.00
CRNX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -167882000.00
CRNX income_statement (annual, 2022-12-31) — Total Unusual Items: 600000.00
CRNX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 600000.00
CRNX balance_sheet (annual, 2022-12-31) — Working Capital: 317461000.00
CRNX income_statement (annual, 2023-12-31) — +Operating Expense: 226621000.00
CRNX income_statement (annual, 2023-12-31) — +Total Revenue: 4013000.00
CRNX balance_sheet (annual, 2023-12-31) — Accounts Payable: 6548000.00
CRNX balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 3051000.00
CRNX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -5068000.00
CRNX cash_flow (annual, 2023-12-31) — Amortization Of Securities: -6271000.00
CRNX income_statement (annual, 2023-12-31) — Basic Average Shares: 58071000.00
CRNX income_statement (annual, 2023-12-31) — Basic EPS: -3.69
CRNX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 33973000.00
CRNX cash_flow (annual, 2023-12-31) — Capital Expenditure: -4688000.00
CRNX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 51728000.00
CRNX balance_sheet (annual, 2023-12-31) — Capital Stock: 1191831000.00
CRNX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 54897000.00
CRNX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 558555000.00
CRNX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 391235000.00
CRNX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -200413000.00
CRNX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -168598000.00
CRNX cash_flow (annual, 2023-12-31) — Change In Inventory: 0.00
CRNX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -546000.00
CRNX cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1535000.00
CRNX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 12357000.00
CRNX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -4523000.00
CRNX cash_flow (annual, 2023-12-31) — Change In Receivables: 0.00
CRNX cash_flow (annual, 2023-12-31) — Change In Working Capital: 5753000.00
CRNX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 0.00
CRNX cash_flow (annual, 2023-12-31) — Changes In Cash: 22224000.00
CRNX balance_sheet (annual, 2023-12-31) — Common Stock: 1191831000.00
CRNX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 539106000.00
CRNX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 369560000.00
CRNX cash_flow (annual, 2023-12-31) — Common Stock Payments: -541000.00
CRNX income_statement (annual, 2023-12-31) — Cost Of Revenue: 0.00
CRNX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 16648000.00
CRNX balance_sheet (annual, 2023-12-31) — Current Assets: 574153000.00
CRNX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4173000.00
CRNX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4173000.00
CRNX balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 2056000.00
CRNX balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 2056000.00
CRNX balance_sheet (annual, 2023-12-31) — Current Liabilities: 43942000.00
CRNX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1098000.00
CRNX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1098000.00
CRNX income_statement (annual, 2023-12-31) — Diluted Average Shares: 58071000.00
CRNX income_statement (annual, 2023-12-31) — Diluted EPS: -3.69
CRNX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -214529000.00
CRNX balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 90000.00
CRNX income_statement (annual, 2023-12-31) — EBIT: -222608000.00
CRNX income_statement (annual, 2023-12-31) — EBITDA: -221510000.00
CRNX income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -5198000.00
CRNX cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 5198000.00
CRNX cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 0.00
CRNX cash_flow (annual, 2023-12-31) — End Cash Position: 56197000.00
CRNX balance_sheet (annual, 2023-12-31) — Financial Assets: 0.00
CRNX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 391235000.00
CRNX cash_flow (annual, 2023-12-31) — Free Cash Flow: -173286000.00
CRNX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 6000.00
CRNX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 977000.00
CRNX income_statement (annual, 2023-12-31) — General And Administrative Expense: 58094000.00
CRNX balance_sheet (annual, 2023-12-31) — Gross PPE: 62498000.00
CRNX income_statement (annual, 2023-12-31) — Gross Profit: 4013000.00
CRNX income_statement (annual, 2023-12-31) — Interest Income: 13436000.00
CRNX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 13436000.00
CRNX balance_sheet (annual, 2023-12-31) — Invested Capital: 539106000.00
CRNX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -200413000.00
CRNX balance_sheet (annual, 2023-12-31) — Investments And Advances: 470000.00
CRNX balance_sheet (annual, 2023-12-31) — Investmentsin Subsidiariesat Cost: 470000.00
CRNX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 369560000.00
CRNX balance_sheet (annual, 2023-12-31) — Leases: 9837000.00
CRNX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 47555000.00
CRNX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 47555000.00
CRNX balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 470000.00
CRNX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1859000.00
CRNX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 369019000.00
CRNX income_statement (annual, 2023-12-31) — Net Income: -214529000.00
CRNX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -214529000.00
CRNX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -214529000.00
CRNX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -214529000.00
CRNX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -214529000.00
CRNX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -214529000.00
CRNX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -214529000.00
CRNX income_statement (annual, 2023-12-31) — Net Interest Income: 13436000.00
CRNX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -195725000.00
CRNX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 13436000.00
CRNX balance_sheet (annual, 2023-12-31) — Net PPE: 57430000.00
CRNX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -4688000.00
CRNX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 539106000.00
CRNX balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 4750000.00
CRNX balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 4750000.00
CRNX income_statement (annual, 2023-12-31) — Normalized EBITDA: -221510000.00
CRNX income_statement (annual, 2023-12-31) — Normalized Income: -214529000.00
CRNX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -168598000.00
CRNX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 5204000.00
CRNX income_statement (annual, 2023-12-31) — Operating Income: -222608000.00
CRNX income_statement (annual, 2023-12-31) — Operating Revenue: 4013000.00
CRNX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 68175000.00
CRNX balance_sheet (annual, 2023-12-31) — Other Current Assets: 448000.00
CRNX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 977000.00
CRNX income_statement (annual, 2023-12-31) — Other Gand A: 58094000.00
CRNX income_statement (annual, 2023-12-31) — Other Income Expense: -5357000.00
CRNX cash_flow (annual, 2023-12-31) — Other Non Cash Items: -790000.00
CRNX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 3300000.00
CRNX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -159000.00
CRNX balance_sheet (annual, 2023-12-31) — Other Properties: 50802000.00
CRNX balance_sheet (annual, 2023-12-31) — Other Receivables: 5463000.00
CRNX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 503658000.00
CRNX balance_sheet (annual, 2023-12-31) — Payables: 6548000.00
CRNX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 23196000.00
CRNX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 14517000.00
CRNX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CRNX balance_sheet (annual, 2023-12-31) — Prepaid Assets: 5799000.00
CRNX income_statement (annual, 2023-12-31) — Pretax Income: -214529000.00
CRNX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 22216000.00
CRNX balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRNX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -532857000.00
CRNX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -4688000.00
CRNX balance_sheet (annual, 2023-12-31) — Receivables: 9351000.00
CRNX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 0.00
CRNX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1098000.00
CRNX cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -541000.00
CRNX income_statement (annual, 2023-12-31) — Research And Development: 168527000.00
CRNX balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
CRNX balance_sheet (annual, 2023-12-31) — Retained Earnings: -653702000.00
CRNX cash_flow (annual, 2023-12-31) — Sale Of Investment: 337132000.00
CRNX income_statement (annual, 2023-12-31) — Selling General And Administration: 58094000.00
CRNX balance_sheet (annual, 2023-12-31) — Share Issued: 68175000.00
CRNX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 40937000.00
CRNX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 539106000.00
CRNX balance_sheet (annual, 2023-12-31) — Tangible Book Value: 539106000.00
CRNX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (annual, 2023-12-31) — Tax Provision: 0.00
CRNX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CRNX balance_sheet (annual, 2023-12-31) — Taxes Receivable: 747000.00
CRNX balance_sheet (annual, 2023-12-31) — Total Assets: 635353000.00
CRNX balance_sheet (annual, 2023-12-31) — Total Capitalization: 539106000.00
CRNX balance_sheet (annual, 2023-12-31) — Total Debt: 51728000.00
CRNX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 539106000.00
CRNX income_statement (annual, 2023-12-31) — Total Expenses: 226621000.00
CRNX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 96247000.00
CRNX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 61200000.00
CRNX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 52305000.00
CRNX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -222608000.00
CRNX balance_sheet (annual, 2023-12-31) — Working Capital: 530211000.00
CRNX balance_sheet (quarterly, 2024-09-30) — Accrued Interest Receivable: 3373000.00
CRNX balance_sheet (quarterly, 2024-09-30) — Duefrom Related Parties Current: 92000.00
CRNX balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 0.00
CRNX balance_sheet (quarterly, 2024-09-30) — Investmentsin Subsidiariesat Cost: 0.00
CRNX balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 0.00
CRNX balance_sheet (quarterly, 2024-09-30) — Other Receivables: 3261000.00
CRNX balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 6405000.00
CRNX balance_sheet (quarterly, 2024-09-30) — Receivables: 7028000.00
CRNX balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 302000.00
CRNX income_statement (annual, 2024-12-31) — +Operating Expense: 339893000.00
CRNX income_statement (annual, 2024-12-31) — +Total Revenue: 1039000.00
CRNX balance_sheet (annual, 2024-12-31) — Accounts Payable: 5853000.00
CRNX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
CRNX balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 0.00
CRNX balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 8310000.00
CRNX balance_sheet (quarterly, 2024-12-31) — Accrued Interest Receivable: 8310000.00
CRNX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -7732000.00
CRNX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -14931000.00
CRNX income_statement (annual, 2024-12-31) — Basic Average Shares: 80783000.00
CRNX income_statement (annual, 2024-12-31) — Basic EPS: -3.69
CRNX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 56197000.00
CRNX cash_flow (annual, 2024-12-31) — Capital Expenditure: -3844000.00
CRNX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 51722000.00
CRNX balance_sheet (annual, 2024-12-31) — Capital Stock: 2275952000.00
CRNX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 264545000.00
CRNX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1354069000.00
CRNX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1014659000.00
CRNX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -574817000.00
CRNX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -230194000.00
CRNX cash_flow (annual, 2024-12-31) — Change In Inventory: 0.00
CRNX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -6000.00
CRNX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 74000.00
CRNX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 13317000.00
CRNX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -5974000.00
CRNX cash_flow (annual, 2024-12-31) — Change In Receivables: 0.00
CRNX cash_flow (annual, 2024-12-31) — Change In Working Capital: 7411000.00
CRNX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
CRNX cash_flow (annual, 2024-12-31) — Changes In Cash: 209648000.00
CRNX balance_sheet (annual, 2024-12-31) — Common Stock: 2275952000.00
CRNX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1324805000.00
CRNX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 985030000.00
CRNX cash_flow (annual, 2024-12-31) — Common Stock Payments: -14982000.00
CRNX income_statement (annual, 2024-12-31) — Cost Of Revenue: 0.00
CRNX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 15616000.00
CRNX balance_sheet (annual, 2024-12-31) — Current Assets: 1375388000.00
CRNX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 7152000.00
CRNX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 7152000.00
CRNX balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 2176000.00
CRNX balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 2176000.00
CRNX balance_sheet (annual, 2024-12-31) — Current Liabilities: 59684000.00
CRNX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2785000.00
CRNX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2785000.00
CRNX income_statement (annual, 2024-12-31) — Diluted Average Shares: 80783000.00
CRNX income_statement (annual, 2024-12-31) — Diluted EPS: -3.69
CRNX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -298408000.00
CRNX balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 0.00
CRNX balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 0.00
CRNX income_statement (annual, 2024-12-31) — EBIT: -338854000.00
CRNX income_statement (annual, 2024-12-31) — EBITDA: -336069000.00
CRNX income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -470000.00
CRNX income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 0.00
CRNX cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 470000.00
CRNX cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
CRNX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
CRNX cash_flow (annual, 2024-12-31) — End Cash Position: 265845000.00
CRNX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1014659000.00
CRNX cash_flow (annual, 2024-12-31) — Free Cash Flow: -234038000.00
CRNX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 51000.00
CRNX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 963000.00
CRNX income_statement (annual, 2024-12-31) — General And Administrative Expense: 99737000.00
CRNX balance_sheet (annual, 2024-12-31) — Gross PPE: 63307000.00
CRNX income_statement (annual, 2024-12-31) — Gross Profit: 1039000.00
CRNX income_statement (annual, 2024-12-31) — Interest Income: 41435000.00
CRNX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 41435000.00
CRNX balance_sheet (annual, 2024-12-31) — Inventory: 0.00
CRNX balance_sheet (quarterly, 2024-12-31) — Inventory: 0.00
CRNX balance_sheet (annual, 2024-12-31) — Invested Capital: 1324805000.00
CRNX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -574817000.00
CRNX balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
CRNX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
CRNX balance_sheet (annual, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
CRNX balance_sheet (quarterly, 2024-12-31) — Investmentsin Subsidiariesat Cost: 0.00
CRNX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 985030000.00
CRNX balance_sheet (annual, 2024-12-31) — Leases: 11900000.00
CRNX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 44570000.00
CRNX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 44570000.00
CRNX balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
CRNX balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
CRNX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2207000.00
CRNX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 970048000.00
CRNX income_statement (annual, 2024-12-31) — Net Income: -298408000.00
CRNX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -298408000.00
CRNX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -298408000.00
CRNX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -298408000.00
CRNX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -298408000.00
CRNX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -298408000.00
CRNX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -298408000.00
CRNX income_statement (annual, 2024-12-31) — Net Interest Income: 41435000.00
CRNX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -570973000.00
CRNX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 41435000.00
CRNX balance_sheet (annual, 2024-12-31) — Net PPE: 55575000.00
CRNX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -3844000.00
CRNX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1324805000.00
CRNX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 4704000.00
CRNX balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 4704000.00
CRNX income_statement (annual, 2024-12-31) — Normalized EBITDA: -336069000.00
CRNX income_statement (annual, 2024-12-31) — Normalized Income: -298408000.00
CRNX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -230194000.00
CRNX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 521000.00
CRNX income_statement (annual, 2024-12-31) — Operating Income: -338854000.00
CRNX income_statement (annual, 2024-12-31) — Operating Revenue: 1039000.00
CRNX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 92926000.00
CRNX balance_sheet (annual, 2024-12-31) — Other Current Assets: 20819000.00
CRNX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 963000.00
CRNX income_statement (annual, 2024-12-31) — Other Gand A: 99737000.00
CRNX income_statement (annual, 2024-12-31) — Other Income Expense: -989000.00
CRNX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3042000.00
CRNX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 3629000.00
CRNX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 829000.00
CRNX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -519000.00
CRNX balance_sheet (annual, 2024-12-31) — Other Properties: 49200000.00
CRNX balance_sheet (annual, 2024-12-31) — Other Receivables: 86000.00
CRNX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 86000.00
CRNX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 1089524000.00
CRNX balance_sheet (annual, 2024-12-31) — Payables: 5853000.00
CRNX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 21469000.00
CRNX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 28887000.00
CRNX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CRNX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 11142000.00
CRNX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 11142000.00
CRNX income_statement (annual, 2024-12-31) — Pretax Income: -298408000.00
CRNX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 44611000.00
CRNX balance_sheet (annual, 2024-12-31) — Properties: 0.00
CRNX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1146772000.00
CRNX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -3844000.00
CRNX balance_sheet (annual, 2024-12-31) — Receivables: 0.00
CRNX balance_sheet (quarterly, 2024-12-31) — Receivables: 0.00
CRNX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
CRNX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2785000.00
CRNX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -14982000.00
CRNX income_statement (annual, 2024-12-31) — Research And Development: 240156000.00
CRNX balance_sheet (annual, 2024-12-31) — Restricted Cash: 500000.00
CRNX balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 500000.00
CRNX balance_sheet (annual, 2024-12-31) — Retained Earnings: -952110000.00
CRNX cash_flow (annual, 2024-12-31) — Sale Of Investment: 575799000.00
CRNX income_statement (annual, 2024-12-31) — Selling General And Administration: 99737000.00
CRNX balance_sheet (annual, 2024-12-31) — Share Issued: 92926000.00
CRNX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 69386000.00
CRNX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1324805000.00
CRNX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1324805000.00
CRNX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
CRNX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CRNX balance_sheet (annual, 2024-12-31) — Taxes Receivable: 74000.00
CRNX balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 74000.00
CRNX balance_sheet (annual, 2024-12-31) — Total Assets: 1434592000.00
CRNX balance_sheet (annual, 2024-12-31) — Total Capitalization: 1324805000.00
CRNX balance_sheet (annual, 2024-12-31) — Total Debt: 51722000.00
CRNX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1324805000.00
CRNX income_statement (annual, 2024-12-31) — Total Expenses: 339893000.00
CRNX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 109787000.00
CRNX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 59204000.00
CRNX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 50103000.00
CRNX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -338854000.00
CRNX balance_sheet (annual, 2024-12-31) — Working Capital: 1315704000.00
CRNX income_statement (quarterly, 2025-03-31) — +Operating Expense: 111766000.00
CRNX income_statement (quarterly, 2025-03-31) — +Total Revenue: 361000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 9842000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 7225000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -8640000.00
CRNX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -4376000.00
CRNX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 93102000.00
CRNX income_statement (quarterly, 2025-03-31) — Basic EPS: -1.04
CRNX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 265845000.00
CRNX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1239000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 50819000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2300882000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 94569000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1274124000.00
CRNX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 4437000.00
CRNX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -85961000.00
CRNX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -88452000.00
CRNX cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -903000.00
CRNX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -361000.00
CRNX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1356000.00
CRNX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -6917000.00
CRNX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -9537000.00
CRNX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -169976000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Common Stock: 2300882000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1254000000.00
CRNX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CRNX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 0.00
CRNX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 21774000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Current Assets: 1291055000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 6883000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 6883000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2206000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2206000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 57311000.00
CRNX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 925000.00
CRNX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 925000.00
CRNX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 93102000.00
CRNX income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.04
CRNX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -96774000.00
CRNX income_statement (quarterly, 2025-03-31) — EBIT: -111405000.00
CRNX income_statement (quarterly, 2025-03-31) — EBITDA: -110480000.00
CRNX income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — End Cash Position: 95869000.00
CRNX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 4437000.00
CRNX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -89691000.00
CRNX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 19000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2002000.00
CRNX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 35526000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 63962000.00
CRNX income_statement (quarterly, 2025-03-31) — Gross Profit: 361000.00
CRNX income_statement (quarterly, 2025-03-31) — Interest Income: 14834000.00
CRNX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 14834000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1254000000.00
CRNX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -85961000.00
CRNX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CRNX balance_sheet (quarterly, 2025-03-31) — Leases: 12986000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 43936000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 43936000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2255000.00
CRNX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CRNX income_statement (quarterly, 2025-03-31) — Net Income: -96774000.00
CRNX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -96774000.00
CRNX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -96774000.00
CRNX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -96774000.00
CRNX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -96774000.00
CRNX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -96774000.00
CRNX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -96774000.00
CRNX income_statement (quarterly, 2025-03-31) — Net Interest Income: 14834000.00
CRNX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -84722000.00
CRNX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 14834000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Net PPE: 55322000.00
CRNX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1239000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1254000000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4313000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 4313000.00
CRNX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -110480000.00
CRNX income_statement (quarterly, 2025-03-31) — Normalized Income: -96774000.00
CRNX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -88452000.00
CRNX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 19000.00
CRNX income_statement (quarterly, 2025-03-31) — Operating Income: -111405000.00
CRNX income_statement (quarterly, 2025-03-31) — Operating Revenue: 361000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 93525000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2702000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2002000.00
CRNX income_statement (quarterly, 2025-03-31) — Other Gand A: 35526000.00
CRNX income_statement (quarterly, 2025-03-31) — Other Income Expense: -203000.00
CRNX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 813000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 14950000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1767000.00
CRNX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -203000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Other Properties: 48721000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 15000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1179555000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Payables: 9842000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 31616000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 16606000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CRNX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 6415000.00
CRNX income_statement (quarterly, 2025-03-31) — Pretax Income: -96774000.00
CRNX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 4437000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CRNX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -391204000.00
CRNX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1239000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Receivables: 7314000.00
CRNX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 0.00